中国血液净化

中国血液净化 ›› 2024, Vol. 23 ›› Issue (10): 767-770.doi: 10.3969/j.issn.1671-4091.2024.10.008

• 综述 • 上一篇    下一篇

维持性血液透析患者高钾血症的特点及管理进展

王羽柔     郭胜杰    袁立英   

  1. 563000 遵义，1遵义医科大学第三附属医院(遵义市第一人民医院)肾脏内科
  • 收稿日期:2024-04-23 修回日期:2024-05-25 出版日期:2024-10-12 发布日期:2024-10-12
  • 通讯作者: 袁立英 E-mail:1260159233@qq.com
  • 基金资助:
    贵州省科技计划项目（黔科合基础-ZK[2024]一般679）；遵义市科技计划项目(遵市科合HZ字(2023)42号)

The characteristics and management of hyperkalemia in patients on maintenance hemodialysis

WANG Yu-rou, GUO Sheng-jie, YUAN Li-ying   

  1. Department of Nephrology, The Third Affiliated Hospital of Zunyi Medical University (The First People's Hospital of Zunyi), Zunyi 563000, China
  • Received:2024-04-23 Revised:2024-05-25 Online:2024-10-12 Published:2024-10-12
  • Contact: 563000 遵义，1遵义医科大学第三附属医院(遵义市第一人民医院)肾脏内科 E-mail:1260159233@qq.com

PDF

33

摘要： 高钾血症是维持性血液透析(maintenance hemodialysis，MHD)患者常见的电解质紊乱，血钾轻度升高患者可无明显症状，但严重血钾升高可引起心搏骤停、致死性心律失常、呼吸机麻痹等并发症，严重影响MHD患者的生存和预后。本文就MHD患者高钾血症的特点及管理进展进行综述。

关键词: 慢性肾脏病, 血液透析, 高钾血症, 降钾药物

Abstract: Hyperkalemia is frequently seen in patients on maintenance hemodialysis (MHD). Patients with slight hyperkalemia may have no obvious symptoms, but severe hyperkalemia can cause cardiac arrest, fatal arrhythmia, ventilator paralysis and other complications, seriously affecting survival and prognosis of the MHD patients. This article aims to review the characteristics and management of hyperkalemia in MHD patients.

Key words: Chronic kidney disease, Hemodialysis, Hyperkalemia, Potassium-lowering drug

中图分类号: